GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Shiller PE Ratio

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Shiller PE Ratio : (As of Jun. 20, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Panacos Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Panacos Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Shiller PE Ratio Chart

Panacos Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.55 -0.92 -0.63 -0.17

Panacos Pharmaceuticals Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 -0.17 -0.16 -0.11 -0.09

Competitive Comparison of Panacos Pharmaceuticals's Shiller PE Ratio

For the Biotechnology subindustry, Panacos Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacos Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacos Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Panacos Pharmaceuticals's Shiller PE Ratio falls into.



Panacos Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Panacos Pharmaceuticals's E10 for the quarter that ended in Sep. 2008 is calculated as:

For example, Panacos Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2008 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2008 (Change)*Current CPI (Sep. 2008)
=-0.15/92.3069*92.3069
=-0.150

Current CPI (Sep. 2008) = 92.3069.

Panacos Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
199812 1.400 69.151 1.869
199903 0.500 69.615 0.663
199906 -2.600 70.122 -3.423
199909 -4.700 70.839 -6.124
199912 -21.100 71.008 -27.429
200003 -0.300 72.231 -0.383
200006 -2.400 72.737 -3.046
200009 -2.500 73.286 -3.149
200012 -2.300 73.413 -2.892
200103 -2.100 74.341 -2.608
200106 -6.400 75.100 -7.866
200109 -1.200 75.227 -1.472
200112 -0.800 74.552 -0.991
200203 -1.700 75.438 -2.080
200206 -2.400 75.902 -2.919
200209 -2.600 76.366 -3.143
200212 -2.000 76.324 -2.419
200303 -2.800 77.716 -3.326
200306 -2.300 77.505 -2.739
200309 -1.600 78.138 -1.890
200312 -6.600 77.758 -7.835
200403 -4.660 79.066 -5.440
200406 -7.410 80.037 -8.546
200409 -2.200 80.121 -2.535
200412 -3.360 80.290 -3.863
200503 -3.660 81.555 -4.143
200506 -0.210 82.062 -0.236
200509 -0.150 83.876 -0.165
200512 -0.010 83.032 -0.011
200603 -0.130 84.298 -0.142
200606 -0.300 85.606 -0.323
200609 -0.160 85.606 -0.173
200612 -0.170 85.142 -0.184
200703 -0.190 86.640 -0.202
200706 -0.190 87.906 -0.200
200709 -0.150 87.964 -0.157
200712 -0.170 88.616 -0.177
200803 -0.160 90.090 -0.164
200806 -0.180 92.320 -0.180
200809 -0.150 92.307 -0.150

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Panacos Pharmaceuticals  (GREY:PANC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Panacos Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacos Pharmaceuticals (Panacos Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
134 Coolidge Avenue, Watertown, MA, USA, 02472
Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Headlines

No Headlines